(PharmaNewsWire.Com, January 12, 2017 ) According to Publisher, the Global Radiotherapy Market is accounted for $6.5 billion in 2015 and is expected to reach $10.2 billion by 2022 growing at a CAGR of 6.6% during the forecast period. Rising number of cancer patients, technological advancements and increasing aging population are some of the key factors fueling the market growth. However, lack of sufficient infrastructure and healthcare costs are expected to hinder the market.
Technologies such as External beam radiotherapy and internal beam radiotherapy are anticipated to witness highest growth owing to increased pool of cancer patients. North America commanded the largest market share as it is constantly inclined to the newer technologies when compared to slow-moving markets such as Europe. Rising incidence of cancer and unmet healthcare needs in APAC provides ample of opportunities for the players in the market over the foreseeable future.
Some of the key players in the market include Siemens Healthcare, GE Healthcare, Nordion, Inc., IBA Group, Angiodynamics Inc, Ion Beam Applications SA, Protom International Inc, IsoRay Medical, Inc., Coviden Plc, Varian Medical Systems Inc, Accuray Inc, Mevion Medical Systems, Inc, C.R. BARD Inc, CIVCO Medical Solutions, Mitsubishi Electric Corporation, Brainlab AG, RaySearch Laboratories AB, Elekta AB and Nanobiotix.
Equipments Covered: -Linear Accelerators -Treatment Planning Systems -Radiation Therapy Simulators
Applications Covered: -Head and Neck Cancer -Breast Cancer -Prostate Cancer -Colorectal Cancer -Spine Cancer -Cervical Cancer -Penile Cancer -Gynaecological Cancer -Skin & Lip Cancer -Lung Cancer -Other Applications
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -France -Italy -UK -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -Rest of Asia Pacific -Rest of the World -Middle East -Brazil -Argentina -South Africa -Egypt
What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements
Company Profiling 11.1 Siemens Healthcare 11.2 GE Healthcare 11.3 Nordion, Inc. 11.4 IBA Group 11.5 Angiodynamics Inc 11.6 Ion Beam Applications SA 11.7 Protom International Inc 11.8 IsoRay Medical, Inc. 11.9 Coviden Plc 11.10 Varian Medical Systems Inc 11.11 Accuray Inc 11.12 Mevion Medical Systems, Inc 11.13 C.R. BARD Inc 11.14 CIVCO Medical Solutions 11.15 Mitsubishi Electric Corporation 11.16 Brainlab AG 11.17 RaySearch Laboratories AB 11.18 Elekta AB 11.19 Nanobiotix
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: